Skip to content

Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy

Yoga or Wellness Education During Breast Cancer Treatment: Establishing Community-Based Partnerships

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00994279
Enrollment
40
Registered
2009-10-14
Start date
2010-01-31
Completion date
2011-10-14
Last updated
2021-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Depression, Fatigue, Sleep Disorders

Keywords

fatigue, depression, sleep disorders, stage IA breast cancer, stage IB breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer, recurrent breast cancer

Brief summary

RATIONALE: Yoga and wellness classes may reduce fatigue and improve mood, sleep, and quality of life in women receiving chemotherapy for breast cancer. It is not yet known whether yoga is more effective than wellness education for women with breast cancer who are undergoing chemotherapy. PURPOSE: This randomized phase II trial is studying a community-based yoga class to see how well it works compared with an educational wellness class for women with stage I, stage II, or stage III breast cancer undergoing chemotherapy.

Detailed description

OBJECTIVES: Primary * To estimate the participation rate, accrual, adherence, and retention to a community-based study of yoga vs an active control (wellness education) in women with stage I-III breast cancer undergoing chemotherapy. Secondary * To obtain estimates of the variability of women's self-reported fatigue and depressive symptoms, sleep quality, and health-related quality of life from baseline to the end of the intervention at 10 weeks. * To obtain estimates of the efficacy of a community-based yoga intervention in women with breast cancer. * To standardize the yoga protocol for use in multiple community settings with breast cancer patients, and ascertain that yoga teachers can adhere to a uniform protocol. OUTLINE: This is a multicenter study. Patients are stratified according to CCOP site and chemotherapy-treatment status (planning vs started). Patients are randomized to 1 of 2 intervention arms. Patients must begin their class or group within 3 weeks of starting chemotherapy. All women enter their class or group on a rolling basis so that their class or group coincides with the weeks that they receive chemotherapy treatments. * Arm I (Yoga intervention): In weeks 1-10, patients attend a community-based weekly 75-minute Integral Yoga class led by an experienced yoga teacher specifically trained in adapting yoga for people with cancer. The yoga class includes postures, deep relaxation, breathing practices, and meditation to create a profound experience of peace and well-being. Women are asked to attend ≥ 8 of 10 classes over a 12-week period to allow for missed classes. Women are also provided with a yoga mat, associated yoga props (bolster, strap), and a 45-minute cancer-specific yoga DVD for home practice. Women are asked to practice yoga outside of the class at least twice per week, and are encouraged to practice more frequently than that. * Arm II (Active control): Patients meet for a weekly 75-minute wellness education group in weeks 1-10 (women may make-up missed classes during weeks 11 and 12). The group focuses on issues that women with breast cancer face as they undergo treatment; topics include symptom management, financial and insurance issues, emotional issues/coping with cancer, communicating with healthcare providers/navigating the healthcare system, healthful eating/cooking demonstrations, sexual issues/fertility/body image, mobilizing social support/impact of cancer on family and friends, survivorship (advocacy) opportunities, and common concerns/fear of recurrence. Women are provided with reading materials relevant to the topics that will be covered in each group meeting and are asked to spend approximately 45 minutes twice weekly reading these materials and incorporating any relevant principles/ideas into their daily lives. Women may request additional reading materials in further topics of interest from the group facilitators. Patients complete questionnaires at baseline and at weeks 5, 10, and 14 to assess fatigue (FACIT-Fatigue), depressive symptoms (Center for Epidemiologic Studies-Depression Scale \[CES-D\]), treatment-related symptoms (M.D. Anderson Symptom Inventory \[MDASI\]), sleep disturbance (Medical Outcomes Study Sleep Measure \[MOS-Sleep\]), and health-related quality of life (Functional Assessment of Cancer Therapy-Breast \[FACT-B\]). Patients also track time spent on all home-yoga practice (arm I) or wellness-group homework (arm II). After the intervention (week 10), patients are asked to provide feedback on the program. Yoga/Wellness teachers will completion intervention feedback forms 6 months from the start of the first intervention and at completion of the study.

Interventions

BEHAVIORALYoga

Yoga sessions

BEHAVIORALEducation

Educational Wellness Group

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Women will be eligible if they are: * Scheduled to begin chemotherapy treatment within 3 weeks of study registration, or able to start Yoga/Wellness sessions prior to second chemotherapy treatment. * ≥18 years of age. * Physically able to attend yoga classes (simply meaning that they can physically make it to the intervention session and are able to sit on a chair or lie on the floor) (ECOG Performance Status rating 0-2; Zubrod et al., 1960). * Diagnosed with breast cancer Stages I-III. * Chemotherapy is anticipated to continue during the 10 weeks of the study intervention. * 2-8 weeks post-completion of breast surgery (unless receiving neoadjuvant chemotherapy). * Ability to understand and the willingness to sign a written informed consent document.

Exclusion criteria

* Have practiced yoga on a regular basis (at least once a week) within the past 4 weeks to recruit women who are not already regularly practicing yoga. Given that the benefits of yoga are likely more immediate than long-term, however, we will enroll women who have previously had a yoga practice. * Are being treated with surgery and/or radiation therapy and/or hormonal treatment only and/or Herceptin therapy only (no chemotherapy). * Anticipate undergoing surgery related to their breast cancer or receipt of radiation therapy during the study period. * Have regularly engaged in moderate (activity that makes you breathe somewhat harder than normal; may include carrying light loads, bicycling at a regular pace, fast walking, tennis, easy swimming, or popular or folk dancing) or vigorous (activity that causes heavy breathing, sweating, rapid fatigue; it can only be sustained for very short periods of time, like running or swimming strongly) physical activity at least 3-5 days per week (on average) within the past 4 weeks. Pregnant women will not be excluded from this study because the study intervention(s) pose no risk of potential for teratogenic or abortifacient effects. In fact, gentle yoga practice is quite safe for pregnant women and poses can be slightly modified, if needed. The anticipated number of pregnant women eligible to enroll is minimal.

Design outcomes

Primary

MeasureTime frameDescription
Retention10 weeksProportion of participants completing the 10 week study

Secondary

MeasureTime frameDescription
Fatigue at 10 Weeks10 weeksFACIT-Fatigue patient reported outcome. This questionnaire consists of 13 questions answered on a 0 to 4 scale with a min of 0 and a max of 52. Higher scores indicate less fatigue.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from three NCI CCOP sites between 1/2010 and 8/2011

Participants by arm

ArmCount
Arm 1: Yoga Intervention
Yoga Intervention Yoga: Yoga sessions
22
Arm 2: Educational Wellness Group
Educational Wellness Group Education: Educational Wellness Group
18
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyMultiple reasons13
Overall StudyToxicity10
Overall StudyWithdrawal by Subject22

Baseline characteristics

CharacteristicArm 1: Yoga InterventionArm 2: Educational Wellness GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants0 Participants3 Participants
Age, Categorical
Between 18 and 65 years
19 Participants18 Participants37 Participants
Age, Continuous50 years45 years47 years
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
22 Participants18 Participants40 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants3 Participants5 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
20 Participants15 Participants35 Participants
Region of Enrollment
United States
22 participants18 participants40 participants
Sex: Female, Male
Female
22 Participants18 Participants40 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
11 / 218 / 17
serious
Total, serious adverse events
1 / 211 / 17

Outcome results

Primary

Retention

Proportion of participants completing the 10 week study

Time frame: 10 weeks

Population: All randomized participants

ArmMeasureValue (NUMBER)
Arm 1: Yoga InterventionRetention82 percentage of participants
Arm 2: Educational Wellness GroupRetention89 percentage of participants
Comparison: Null hypothesis is that the two arms will not differ in retention at 14 weeks.p-value: 0.53Chi-squared
Secondary

Fatigue at 10 Weeks

FACIT-Fatigue patient reported outcome. This questionnaire consists of 13 questions answered on a 0 to 4 scale with a min of 0 and a max of 52. Higher scores indicate less fatigue.

Time frame: 10 weeks

Population: Participants with 10 week outcome data. Note that one participant in the Wellness group was missing this outcome even though they completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Arm 1: Yoga InterventionFatigue at 10 Weeks30.2 units on a scaleStandard Error 2.6
Arm 2: Educational Wellness GroupFatigue at 10 Weeks30.1 units on a scaleStandard Error 2.9
Comparison: Null hypothesis is that the two groups would not differ in fatigue at 10 weeks.p-value: 0.98Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026